XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 12,848 $ 18,263
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of deferred leasing costs 14,523 12,029
Amortization of deferred debt costs 627 564
Non-cash compensation costs of stock and option grants 428 219
Credit losses on operating lease receivables, net 387 342
(Increase) decrease in accounts receivable and accrued income (26) 1,876
Additions to deferred leasing costs (1,161) (1,262)
Decrease in other assets 2,793 377
Increase in accounts payable, accrued expenses, and other liabilities 2,913 2,558
Decrease in deferred income (2,958) (1,138)
Net cash provided by operating activities 30,374 33,828
Cash flows from investing activities:    
Additions to real estate investments (8,787) (5,832)
Additions to development and redevelopment projects (15,697) (39,737)
Net cash used in investing activities (24,484) (45,569)
Cash flows from financing activities:    
Repayments on mortgage notes payable (8,731) (8,527)
Proceeds from revolving credit facility 25,000 27,000
Repayments on revolving credit facility (16,000) (29,000)
Proceeds from construction loans payable 11,177 31,533
Additions to deferred debt costs (133) 0
Proceeds from the issuance of:    
Common stock 598 603
Partnership units 1,629 11,741
Distributions to:    
Common stockholders (14,254) (14,208)
Noncontrolling interests (6,184) (5,930)
Net cash provided by (used in) financing activities (9,697) 10,413
Net decrease in cash and cash equivalents (3,807) (1,328)
Cash and cash equivalents, beginning of period 10,299 8,407
Cash and cash equivalents, end of period 6,492 7,079
Supplemental disclosure of cash flow information:    
Cash paid for interest 16,231 11,960
Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities 23,328 34,573
Series D Cumulative Redeemable, 30,000 shares issued and outstanding    
Distributions to:    
Preferred stockholders (1,149) (1,149)
Series E Cumulative Redeemable, 44,000 shares issued and outstanding    
Distributions to:    
Preferred stockholders $ (1,650) $ (1,650)